Is physiotherapy in migraines known to sufferers? A cross-sectional study.
Headache management
Integrative treatment
Migraine
Migraine interventions
Physiotherapy
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
Apr 2024
Apr 2024
Historique:
received:
24
10
2023
accepted:
07
11
2023
medline:
18
3
2024
pubmed:
15
11
2023
entrez:
15
11
2023
Statut:
ppublish
Résumé
Migraine, a prevalent neurological condition, often impairs daily functioning and quality of life. While medications are the primary treatment, the potential of physiotherapy as an integrative approach remains underexplored. The aim of the study was to explore the awareness and experience of migraine patients regarding physiotherapy as a complementary treatment. A comprehensive survey was conducted on 200 migraine patients. Data collected included demographics, diagnosis, Migraine Disability Assessment Score Questionnaire (MIDAS) scores, and perceptions and experiences related to physiotherapy. The average age of participants was 47.7 ± 13.2 years, with a predominance of females, 149 out of 200 (74.5%). The mean MIDAS score was 36.7 ± 45.3, indicating a significant impact on daily life. While 39 out of 200 (19.5%) had undergone physiotherapy for their headache, 161 out of 200 (80.5%) had not. Of those who had, 22 out of 39 (56.4%) reported benefits, including reduced attack intensity and frequency. Interestingly, 145 out of 161 (90.1%) expressed interest in physiotherapy, with many expecting it to reduce attack intensity, 57 out of 200 (28.5%) and frequency, 77 out of 200 (38.5%). The study highlights the substantial burden of migraines and the potential of physiotherapy as an adjunctive treatment. Increasing awareness and accessibility to physiotherapy could offer migraine patients a more holistic treatment approach; however, randomized controlled trials are mandatory in order to confirm its efficacy.
Sections du résumé
BACKGROUND
BACKGROUND
Migraine, a prevalent neurological condition, often impairs daily functioning and quality of life. While medications are the primary treatment, the potential of physiotherapy as an integrative approach remains underexplored. The aim of the study was to explore the awareness and experience of migraine patients regarding physiotherapy as a complementary treatment.
METHODS
METHODS
A comprehensive survey was conducted on 200 migraine patients. Data collected included demographics, diagnosis, Migraine Disability Assessment Score Questionnaire (MIDAS) scores, and perceptions and experiences related to physiotherapy.
RESULTS
RESULTS
The average age of participants was 47.7 ± 13.2 years, with a predominance of females, 149 out of 200 (74.5%). The mean MIDAS score was 36.7 ± 45.3, indicating a significant impact on daily life. While 39 out of 200 (19.5%) had undergone physiotherapy for their headache, 161 out of 200 (80.5%) had not. Of those who had, 22 out of 39 (56.4%) reported benefits, including reduced attack intensity and frequency. Interestingly, 145 out of 161 (90.1%) expressed interest in physiotherapy, with many expecting it to reduce attack intensity, 57 out of 200 (28.5%) and frequency, 77 out of 200 (38.5%).
CONCLUSIONS
CONCLUSIONS
The study highlights the substantial burden of migraines and the potential of physiotherapy as an adjunctive treatment. Increasing awareness and accessibility to physiotherapy could offer migraine patients a more holistic treatment approach; however, randomized controlled trials are mandatory in order to confirm its efficacy.
Identifiants
pubmed: 37966625
doi: 10.1007/s10072-023-07195-9
pii: 10.1007/s10072-023-07195-9
pmc: PMC10942894
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1669-1674Informations de copyright
© 2023. The Author(s).
Références
Cephalalgia. 2018 Jan;38(1):1-211
pubmed: 29368949
Neurology. 2009 Feb 3;72(5 Suppl):S3-7
pubmed: 19188564
J Headache Pain. 2011 Apr;12(2):127-33
pubmed: 21298314
J Headache Pain. 2015 Dec;16(Suppl 1):A7
pubmed: 28132381
J Headache Pain. 2023 Jul 12;24(1):84
pubmed: 37438700
J Headache Pain. 2021 Oct 21;22(1):126
pubmed: 34674632
Cephalalgia. 2016 Apr;36(5):474-92
pubmed: 26229071
Neurology. 2001;56(6 Suppl 1):S20-8
pubmed: 11294956
J Integr Neurosci. 2023 Aug 16;22(5):126
pubmed: 37735140
Neurol Sci. 2018 Jun;39(Suppl 1):131-133
pubmed: 29904835
Neurol Sci. 2003 May;24 Suppl 2:S97-100
pubmed: 12811603
J Headache Pain. 2020 Apr 29;21(1):42
pubmed: 32349653
Curr Pain Headache Rep. 2023 Nov;27(11):663-672
pubmed: 37610505
Musculoskelet Sci Pract. 2023 Aug;66:102803
pubmed: 37331925
Cephalalgia. 2016 Oct;36(12):1134-1142
pubmed: 26660851
Musculoskelet Sci Pract. 2023 Aug;66:102786
pubmed: 37291009
Neurology. 2002 Apr 9;58(7):1062-5
pubmed: 11940693
Braz J Phys Ther. 2020 Jul - Aug;24(4):306-317
pubmed: 31813696
Headache. 2015 Oct;55(9):1301-8
pubmed: 26422648
Cephalalgia. 2022 Jan;42(1):63-72
pubmed: 34404258
Cephalalgia. 2010 May;30(5):599-609
pubmed: 19614702
Cephalalgia. 2009 Jun;29(6):597-605
pubmed: 19228150
Man Ther. 2009 Oct;14(5):531-8
pubmed: 19027342
BMJ. 2014 Mar 24;348:g1416
pubmed: 24662044
Neurology. 2008 Aug 19;71(8):559-66
pubmed: 18711108
Headache. 2008 Sep;48(8):1157-68
pubmed: 18808500
Front Neurol. 2019 Mar 26;10:276
pubmed: 30972008
Headache. 2019 Apr;59(4):532-542
pubmed: 30973196
Man Ther. 2008 Oct;13(5):387-96
pubmed: 18316238
J Headache Pain. 2022 Nov 23;23(1):149
pubmed: 36418943